In chronic obstructive pulmonary disease (COPD), GZMB is highly expressed in type II alveolar epithelial cells (Ngan et al., 2009), monocytes, and granulocytes, indicating its role as a key mediator in non-immune cells. Here, GZMB is linked to chronic obstructive pulmonary disease.